Brief: Sedana Medical Q1 Net Income at SEK -16.1 Million
27/04/2023 06:18
Apr 27 (Reuters) - Sedana Medical Q1 sales SEK 37.8 million. * Q1 EBIT margin -43% * Q1 adjusted EPS SEK -0.16 * Q1 net income SEK -16.1 million * Q1 EBITDA SEK -10.7 million * Q1 cash flow from operating activities SEK -7 million
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln